Search Results 121-130 of 263 for ☆【아시아365.COM / 가입코드GK】 땅콩검증 BLACK가입☆

  1. A Study to Establish a Registry of Guardant360® Use and Outcomes In People With Advanced Cancer - Mayo Clinic

    The purpose of this registry is to collect data that describes the characteristics of people with advanced cancer for whom the Guardant360 assay is ordered and ...

  2. A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma - Mayo Clinic

    The main objective of this study is to assess the safety and tolerability of AMG 691 as single doses (healthy participants only) and multiple doses in healthy ...

  3. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

    The study includes a dose escalation phase to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) and an expansion phase to ...

  4. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Mayo Clinic Appointment Services representative in Indonesia

    Jalan Asia Afrika no. 8 Jakarta Selatan Jakarta, Indonesia. Office Hours. 9 a.m. to 5 p.m. Western Indonesia Time, Monday through Friday. Leave the details to ...

  6. OPsumit USers Registry - Clinical Trials

    About this study. Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) ...

  7. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

    The purpose of this study is to test any good and bad effects of adding the drug Blinatumomab to different doses of standard combination of chemotherapy drugs.

  8. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    The primary objective of Substudy 2 (Phase 3 induction) is to evaluate the efficacy and safety of upadacitinib 45 mg QD compared to placebo in inducing clinical ...

  9. Fosfomycin (oral route) - Side effects & dosage - Mayo Clinic

    black, tarry stools; bloating; chest pain; clay-colored stools; constipation; dark urine; diarrhea; difficulty with swallowing; dizziness; fast heartbeat ...

  10. DN24-02 as Adjuvant Therapy in Subjects with High Risk HER2+ Urothelial Carcinoma - Mayo Clinic

    About this study. This study is being conducted to examine survival, safety, and the magnitude of the immune response induced following administration of ...